Ayres D.C. Lignans: chemical, biological, and clinical properties (Cambridge, 2008). - ОГЛАВЛЕНИЕ / CONTENTS
Навигация

 
Выставка новых поступлений  |  Поступления иностранных книг в библиотеки СО РАН : 2003 | 2006 |2008
ОбложкаAyres D.C. Lignans: chemical, biological, and clinical properties / Ayres D.C., Loike J.D. - Cambridge: Cambridge University Press, 2008. - 402 p. - (Chemistry and pharmacology of natural products). - ISBN 0-521-06543-7
 

Оглавление / Contents
 
Preface ........................................................ xi
Glossary for lignans ......................................... xiii

1 Introduction .................................................. 1
Nomenclature .................................................... 4
  Absolute configuration ........................................ 8
  Correlation of absolute configurations ........................ 9
  References ................................................... 10
	
2 A registry of the natural lignans ............................ 12
  The order of the material .................................... 12
  Absolute configuration ....................................... 14
  Arrangement of individual entries
      (i) The Chemical Abstracts Registry number ............... 15
      (ii) Literature references ............................... 16
      (iii) Structural diagrams ................................ 16
  References for the preamble .................................. 16
  Structures and references in the registry .................... 17
	
3 Biological and clinical properties of podophyllotoxin and
  other lignans ................................................ 85
  Introduction ................................................. 85
  Use of lignans in folk and modern medicine ................... 85
      (i) History of podophyllotoxin ........................... 87
  Biological properties and mechanism of action of		
  podophyllotoxin .............................................. 90
      (i) Microtubules ......................................... 90
      (ii) Antiviral properties ................................ 93
      (iii) Nucleoside transport ............................... 94
      (iv) Antitumour effects .................................. 95
  Mammalian lignans ............................................ 95
      (i) Structure ............................................ 95
      (ii) Biological properties ............................... 97
  Structure and biological activity of other lignans ........... 98
      (i) Acyclic lignans ...................................... 98
      (ii) Arylnaphthalenes .................................... 99
      (iii) Dibenzocyclo-octadienes (bridged biphenyls) ....... 100
      (iv) Lignans acting on cyclic adenosine-3',5'-
  monophosphate (cAMP)......................................... 100
    (v) Lignans acting on platelet activating factor (PAF) .... 102
    (vi) Biological effects of lignans on plants and
    insects ................................................... 103
  Conclusions ................................................. 105
  References .................................................. 106

4 Etoposide and Teniposide .................................... 113
  Introduction ................................................ 113
  Clinical applications ....................................... 114
  Structure and synthesis ..................................... 116
  Mechanism of action ......................................... 117
      (i) Inhibition of nucleoside transport .................. 118
      (ii) DNA effects ........................................ 118
      (iii) Effects on oxidative phosphorylation .............. 122
  Cell sensitivity and resistance towards Etoposide ........... 122
  Structure/activity studies - DNA effects .................... 125
  Pharmacokinetics and pharmacology ........................... 127
      (i) Cellular uptake of Etoposide and Teniposide ......... 127
      (ii) Pharmacokinetics ................................... 128
      (iii) Metabolism ........................................ 129
      (iv) Toxicity ........................................... 130
  Conclusions and future studies .............................. 130
  References .................................................. 132

5 Isolation, purification and initial characterisation ........ 138
  Plant root sources .......................................... 138
  Leaf and stem sources ....................................... 140
  Seeds as sources ............................................ 140
  Fruits as sources ........................................... 141
  Resin and heartwood sources ................................. 142
  Lignan glycosides ........................................... 144
  Isolation procedures ........................................ 145
      (i) Solvent extraction .................................. 145
      (ii) Fractional extraction .............................. 146
      (iii) Separation by precipitation ....................... 148
      (iv) Extraction of polar lignans from biological
      materials ............................................... 148
  Chromatographic methods ..................................... 149
      (i) Thin layer chromatography ........................... 149
      (ii) Column chromatography .............................. 151
      (iii) High-performance liquid chromatography............. 153
      (iv) Gas-liquid chromatography........................... 155
  Formation of artefacts ...................................... 156
      (i) Changes induced by bases............................. 156
      (ii) Changes induced by acids............................ 157
  References .................................................. 159

6 Determination of structure .................................. 166
  Ultraviolet absorption spectra .............................. 166
  Dibenzocyclo-octadiene lignans .............................. 170
  Arylnaphthalene lignans ..................................... 170
  Infrared absorption spectra ................................. 170
    (i) Lignan solvates ....................................... 171
    (ii) Preparation of the sample ............................ 171
    (iii) Functional group responses .......................... 171
  Mass spectra ................................................ 175
  Diarylbutanes and diarylbutyrolactones ...................... 177
  Tetrahydrofurans (epoxylignans) ............................. 180
  Furofurans (bisepoxylignans) ................................ 183
  Oxofurofurans ............................................... 185
  Aryltetralins ............................................... 186
  Arylnaphthalenes ............................................ 190
  Dibenzocyclo-octadienes ..................................... 191
  Lignan conjugates ........................................... 192
  Nuclear magnetic resonance spectra .......................... 195
      (i) Introductory remarks ................................ 195
      (ii) Aromatic substitution patterns ..................... 195
      (iii) Dibenzylbutanes and dibenzylbutyrolactones ........ 197
      (iv) 13-CNMR spectroscopy ............................... 199
  Furans ...................................................... 202
      (i) 9,9'-Epoxylignans ................................... 202
      (ii) 7,7'-Epoxylignans .................................. 203
      (iii) 7,9'-Epoxylignans ................................. 206
  Furofurans .................................................. 208
  Chemical correlation of furofurans and furans ............... 213
  Aryltetrahydronaphthalenes .................................. 216
      (i) Orientation of aromatic substituents ................ 219
      (ii) Use of CM R spectra ................................ 220
      (iii) Aryltetrahydronaphthalene lactones ................ 221
      (iv) Absolute configuration ............................. 228
  Dibenzocyclo-octadiene lignans .............................. 230
      (i) Orientation of aromatic substituents ................ 235
      (ii) The steganacin subgroup ............................ 237
  Lignan conjugates ........................................... 242
  Higher glycosides ........................................... 246
  Optical rotatory dispersion and circular dichroism .......... 247
      (i) Optical rotatory dispersion ......................... 247
      (ii) Circular dichroism ................................. 249
      (a) Dibenzylbutyrolactones .............................. 249
      (b) Furans and furofurans ............................... 249
      (c) Aryltetrahydronaphthalenes .......................... 253
      (d) Compounds with inherent dissymmetry ................. 256
  References .................................................. 257

7 Biosynthesis ................................................ 269
  The chemistry of lignin ..................................... 269
  Cleavage of lignin .......................................... 273
      (i) Acidic cleavage ..................................... 273
      (ii) Alkaline cleavage .................................. 274
      (iii) Enzymic cleavage .................................. 275
  Oligomers of cinnamic acid .................................. 275
  Lignan biosynthesis ......................................... 278
      (i) The quinone methide mechanism ....................... 279
      (ii) Biomimetic synthesis ............................... 280
      (iii) Experiments in vivo ............................... 287
      (a) Preliminary studies and structural correlations ..... 287
      (b) The tetrahydronaphthalene group ..................... 291
      (c) Apolignans and arylnaphthalenes ..................... 295
      (d) Biogenesis of ether groups 296 References ........... 298

  Synthesis ................................................... 303
  Oxidative coupling .......................................... 303
  Dibenzylbutanes and dibenzylbutyrolactones .................. 306
      (i) The Stobbe condensation ............................. 306
      (ii) Other syntheses initiated by carbanions ............ 310
      (iii) Stereoselective synthesis ......................... 313
      (iv) Conjugate additions ................................ 315
  Oxygenation of the side chain ............................... 318
  Reactions with N-bromosuccinamide and dichlorodicyano-  
  1,4-benzoquinone ............................................ 322
  Diels-Alder syntheses ....................................... 325
  Routes to specific classes of lignins ....................... 330
  Arylnaphthalenes ............................................ 330
  Furans ...................................................... 333
      (i) 9,9'-Epoxylignans ................................... 333
      (ii) 7,7'-Epoxylignans .................................. 334
      (a) The bicyclic lactone route .......................... 337
      (iii) 7,9'-Epoxylignans ................................. 338
  Furofurans(7,9':7',9-diepoxylignans) ........................ 339
      (i) Synthesis of monolactones ........................... 340
      (ii) Synthesis of dilactones ............................ 341
      (a) Unsymmetrical dilactones ............................ 342
  Dibenzocyclo-octadienes ..................................... 344
      (i) Oxidative coupling .................................. 345
      (ii) Ullmann synthesis .................................. 346
      (iii) Elaboration of phenanthrenes ...................... 350
  Dihydro- and tetrahydronaphthalenes ......................... 354
      (i) Summary of above procedures relevant to tetralin  
  synthesis ................................................... 354
      (a) Oxidative coupling .................................. 354
      (b) Development of the Stobbe and carbanion  
      condensation products ................................... 355
      (c) Oxidative cyclisation ............................... 355
      (d) Diels-Alder synthesis ............................... 356
      (ii) Modification of other lignans by Friedel-Crafts  
      cyclisation ............................................. 357
      (iii) Synthesis of podophyllotoxins ..................... 362
      (a) Bristol-Myers group syntheses ....................... 368
      (iv) Derivatives of podophyllotoxins .................... 370
  References .................................................. 373
  Botanical index ............................................. 385
  General index ............................................... 385


 
Выставка новых поступлений  |  Поступления иностранных книг в библиотеки СО РАН : 2003 | 2006 |2008
 

[О библиотеке | Академгородок | Новости | Выставки | Ресурсы | Библиография | Партнеры | ИнфоЛоция | Поиск]
  © 1997–2024 Отделение ГПНТБ СО РАН  

Документ изменен: Wed Feb 27 14:52:46 2019. Размер: 16,189 bytes.
Посещение N 1760 c 26.04.2010